These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12396727)

  • 1. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin.
    Misery L
    J Interferon Cytokine Res; 2002 Aug; 22(8):881-2. PubMed ID: 12396727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
    Li Z; Zhang Y; An J; Feng Y; Deng H; Xiao S; Ji F
    J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual adverse effect of interferon: hypertrichosis of the eyelashes.
    Ozdoğan M; Gür G; Kadayifcilar S; Boyacioğlu S; Ozgür O; Teletar H
    J Interferon Cytokine Res; 2000 Jul; 20(7):633-4. PubMed ID: 10926205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.
    Sylvestre DL; Disston AR; Bui DP
    J Viral Hepat; 2003 Nov; 10(6):467-70. PubMed ID: 14633182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].
    Yaghi C; Baz P; Koussa S; Daniel F; Haddad F; Sayegh R
    Gastroenterol Clin Biol; 2005 May; 29(5):616-7. PubMed ID: 15980766
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving strategies to attack hepatitis C.
    Norton M
    GMHC Treat Issues; 1998 Dec; 12(12):1-5. PubMed ID: 11366019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.
    Lafeuillade A; Hittinger G; Chadapaud S
    Lancet; 2001 Jan; 357(9252):280-1. PubMed ID: 11214134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.
    Duan J; Wang Y; Liu D; Ma J
    Ocul Immunol Inflamm; 2019; 27(2):229-234. PubMed ID: 29023176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side effects. Bone problems may occur with hepatitis treatment.
    TreatmentUpdate; 2000 Sep; 12(6):7-8. PubMed ID: 12132465
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon alpha and hypertrichosis of eyelashes.
    Dikici B; Bosnak M; Dagli A; Haspolat K
    Pediatr Infect Dis J; 2002 May; 21(5):448-9. PubMed ID: 12150190
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature.
    Ahmad U; Li X; Sodeman T; Daboul I
    Am J Ther; 2013; 20(5):585-7. PubMed ID: 21317616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha].
    Acero D; Adrados M; González-Huix F; Figa M
    Gastroenterol Hepatol; 1996 May; 19(5):243-6. PubMed ID: 8752565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New combination treatment for hepatitis C is more beneficial than standard therapy, study says.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Oct; 13(20):5-6. PubMed ID: 12599388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe local cutaneous necrosis during treatment with interferon-alpha and ribavirin for chronic viral hepatitis C].
    de Ledinghen V; Brudieux E; Beylot-Barry M; Belleannee G; Doutre MS; Couzigou P
    Gastroenterol Clin Biol; 1997; 21(6-7):523-4. PubMed ID: 9295983
    [No Abstract]   [Full Text] [Related]  

  • 18. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.
    Hoffman RG; Cohen MA; Alfonso CA; Weiss JJ; Jones S; Keller M; Condemarín JR; Chiu NM; Jacobson JM
    Psychosomatics; 2003; 44(5):417-20. PubMed ID: 12954918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.